Ⅰ.Introduction Tissue Plasminogen Activator (tPA) is a new clot-specific fibrinolytic agent, developed through gene cloning. It is a 70,000 dalton serine prote
<正> Purpose To present a novel approach for the control of IOP in neovascular glaucoma Setting Oxford Eye Centre and University of the Witwatersrand, Johannesb